Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage.
The p53 tumor suppressor protein functions to monitor the integrity of the genome. If a damage is detected, p53 binds tightly to specific sequence elements in the DNA and induces the transactivation of genes involved in various growth regulatory processes such as cell cycle progression, DNA repair and apoptosis. A p53-binding site was recently identified in the promoter region of the metastatic suppressor KAI1 gene, suggesting that this gene was a direct transcriptional target of p53. To test the relevance of this hypothesis, we studied the endogenous KAI1 expression in a series of human cell lines with varying p53 status in response to genotoxic treatment as well as in different cellular models exhibiting an inducible p53 activity. Overall, our data indicate that KAI1 expression is not significantly modulated by p53. This observation provides a direct evidence that the presence of a p53-binding site in regulatory domains is not a sufficient criteria to define a p53-transcriptional target gene.
Duriez
C
C
Département d'Oncologie Fondamentale et Appliquée, INSERM Unité 453. Centre Léon Bérard, 28 rue Laënnec, 69008, Lyon, France.
Falette
N
N
Cortes
U
U
Moyret-Lalle
C
C
Puisieux
A
A
D015703:Antigens, CD; D004249:DNA Damage; D006801:Humans; D051861:Kangai-1 Protein; D008562:Membrane Glycoproteins; D009362:Neoplasm Metastasis / Q000235:genetics*; D011518:Proto-Oncogene Proteins; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D015703:Antigens, CD; C497688:CD82 protein, human; D051861:Kangai-1 Protein; D008562:Membrane Glycoproteins; D011518:Proto-Oncogene Proteins; D016159:Tumor Suppressor Protein p53